About August Bioservices
August Bioservices is a company based in Nashville (United States) founded in 2017. August Bioservices has raised $88.6 million across 3 funding rounds from investors including Oak HC/FT and Polaris Partners. The company has 86 employees as of December 31, 2021. August Bioservices offers products and services including cGMP Manufacturing, cGMP Laboratory Services, and Research and Development. August Bioservices operates in a competitive market with competitors including Exela Pharma, Gland Pharma, ApiJect, Vetter Pharma and INCOG BioPharma Services, among others.
- Headquarter Nashville, United States
- Employees 86 as on 31 Dec, 2021
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$88.6 M (USD)
in 3 rounds
-
Latest Funding Round
$65 M (USD), Series B
Dec 01, 2022
-
Investors
Oak HC/FT
& 1 more
-
Employee Count
86
as on Dec 31, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of August Bioservices
August Bioservices offers a comprehensive portfolio of products and services, including cGMP Manufacturing, cGMP Laboratory Services, and Research and Development.
Handles sterile fill/finish for pharmaceuticals
Conducts analytical and extractables testing
Offers full programs for drug creation
People of August Bioservices
Unlock access to complete
Funding Insights of August Bioservices
August Bioservices has successfully raised a total of $88.6M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $65 million completed in December 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in August Bioservices
August Bioservices has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Oak HC/FT and Polaris Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are made in early-stage healthtech and fintech startups.
|
Locked | Locked | Locked | |
|
US focused venture capital firm
|
Locked | Locked | Locked |
Investor details for August Bioservices
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by August Bioservices
Investment portfolio details for August Bioservices
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - August Bioservices
Detailed financials for August Bioservices
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
August Bioservices Comparisons
Peer comparison for August Bioservices
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of August Bioservices
August Bioservices operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Exela Pharma, Gland Pharma, ApiJect, Vetter Pharma and INCOG BioPharma Services, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Sterile injectable pharmaceuticals are manufactured alongside CDMO services.
|
|
| Locked | Locked | Locked |
Generic injectable drugs are manufactured across therapeutic segments.
|
|
| Locked | Locked | Locked |
Medicine injectors are manufactured by ApiJect for medical applications.
|
|
| Locked | Locked | Locked |
CDMO specializing in aseptically prefilled syringe systems, cartridges and vials.
|
|
| Locked | Locked | Locked |
Injectable drug products are manufactured by this biopharma CDMO.
|
Detailed competitors of August Bioservices
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on August Bioservices
Complete news archive for August Bioservices
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about August Bioservices
August Bioservices was founded in 2017 and raised its 1st funding round 3 years after it was founded.
August Bioservices is headquartered in Nashville, United States. It is registered at Nashville, Tennessee, United States.
Jenn Adams is the current CEO of August Bioservices.
August Bioservices is a funded company, having raised a total of $88.6M across 3 funding rounds to date.
As of Dec 31, 2021, the latest employee count at August Bioservices is 86.
Provider of diversified research services for clinical solutions. The company provides services in the functional characterization development of assay and in-vitro services. Drug discovery, protein engineeringprotein therapeutics using cytokines, enzymes, fusion proteins, humanized monoclonal antibody, mAbs, and protein conjugates, and cell line development are provided. Formulation, process design, analytical method development solutions are available for pharma development. Labeling, kitting, and other support services are provided for clinical manufacturing.
August Bioservices's top competitors include Exela Pharma, Gland Pharma and Luoxin Pharmaceutical Group.
August Bioservices offers cGMP Manufacturing, cGMP Laboratory Services, and Research and Development.
August Bioservices has 2 investors. Key investors include Oak HC/FT, and Polaris Partners.